NAD+ Pathway

NR (Nicotinamide Riboside)

Compounding-legal

Also known as: Tru Niagen, Niagen

Most-studied NAD+ precursor in humans — Tru Niagen has 30+ clinical trials.

Mechanism

NAD+ precursor. Most-studied NAD+ precursor in humans — Tru Niagen has 30+ clinical trials. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.

Peer-Reviewed Studies (2)

Nicotinamide Riboside Effects on NAD+ in Humans

Nat Commun · 2018

Trammell et al.: oral NR raised blood NAD+ ~50% with 1000mg dose.

PubMed PMID 30202060

NR for Metabolic Health Meta-Analysis

Aging · 2022

NR elevated NAD+ and improved insulin sensitivity in some populations.

PubMed PMID 36490326

Related Compounds